These mouse models have been instrumental in defining the physiological role of Cx26 in mammalian hearing and have served as in vivo platforms for testing emerging gene therapy and genome-editing strategies for GJB2-related deafness [9,11]. The gene discussed is GJB2; the disease is deafness.